The opioid use disorder treatment market consists of medication-assisted treatment (MAT) such as buprenorphine and methadone and extended-release injection treatment. These treatments are aimed at managing withdrawal symptoms, reducing opioid abuse related harms and decreasing the desire to use opioids. MAT has shown to improve treatment retention and reduce the use of illicit opioids.
The...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian